---
schema_version: "secwatch.filing_event.v1"
accession: "0001689548-23-000162"
form_type: "8-K"
ticker: "PRAX"
cik: "0001689548"
company_name: "Praxis Precision Medicines, Inc."
filed_at: "2023-12-01T23:59:59+00:00"
generated_at: "2026-06-07T19:24:08.759861+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Praxis Precision Medicines effects 1-for-15 reverse stock split effective Nov 28, 2023

## Summary
- Every 15 shares of common stock reclassified into 1 share; no change in authorized shares or par value.
- No fractional shares issued; cash payment based on closing price on Nov 28, 2023.
- Trading on Nasdaq begins split-adjusted on Nov 29, 2023 under same symbol PRAX; new CUSIP 74006W207.
- Updated selected financial data in Exhibit 99.1 retroactively adjusts per-share amounts for the split.

## SEC filing metadata
- accession: 0001689548-23-000162
- form_type: 8-K
- ticker: PRAX
- cik: 0001689548
- company_name: Praxis Precision Medicines, Inc.
- filed_at: 2023-12-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1689548/000168954823000162/0001689548-23-000162-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1689548/000168954823000162/prax-20231128.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001689548-23-000162
- JSON: https://secwatch.observer/filing/0001689548-23-000162.json
- Plain text: https://secwatch.observer/filing/0001689548-23-000162.txt

## Key facts
- Governance Changes
  Praxis Precision Medicines, Inc.: Filing of Certificate of Amendment to Amended and Restated Certificate of Incorporation to effect a 1-for-15 reverse stock split (effective 2023-11-28).
  - Change: charter amendment
  - Effective: 2023-11-28
  source text: On November 28, 2023, Praxis Precision Medicines, Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware to effect a 1-for-15 reverse stock split of its common stock (the “Reverse Stock Split”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1689548/000168954823000162/0001689548-23-000162-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.